Community securitizing medical research and development

Public health delivery is a public good. But it is often an overlooked and underappreciated area in the greater part of the globe and particularly in the developing south. But alarmingly underfunded is the medical research across the greater part of even those countries which have a significant presence in the public sector health services delivery. As much as we may despise statistics, according to the WHO, the world’s medical expenditure (2017) stands at US$ 7.8 trillion. The countries spending the most on health care today allocate between 3% and 14% of their total gross domestic product (GDP) on health care costs. Now, at a sharp contrast, public funding for global health research and development (R&D) stood at US$2.3 billion in 2017, according to Policy Cures Research’s G-FINDER report [1]. To make matters worse, public funding for global health R&D is heavily concentrated amidst a few donors only. In 2017, the US provided two-thirds of all public funding, US$1.6 billion, in public sector R&D in the medical sector. The second-largest donor was the UK (US$186 million, 8% of all funding), followed by EU institutions (US$119 million, 5%); for the second year in a row, India was the fourth-largest donor (US$76 million, 3%), and was followed by Germany (US$65 million, 3%).

The OECD’s STAN Database[2] reveals the following additional information[3]:

Year Australia US Dollar, Millions Canada US Dollar, Millions France US Dollar, Millions Germany US Dollar, Millions Italy US Dollar, Millions Japan US Dollar, Millions Spain US Dollar, Millions Sweden US Dollar, Millions United Kingdom US Dollar, Millions United States US Dollar, Millions
2000 209 517 792 616 633 823 289 23 1,352 18,766
2001 255 706 926 729 727 902 130 15 1,467 21,741
2002 291 856 997 754 .. 964 486 15 1,535 24,754
2003 360 943 926 810 .. 1,032 569 23 1,670 27,335
2004 365 966 942 837 .. 1,040 744 24 1,784 29,346
2005 575 1,084 1,068 853 1,108 1,076 759 24 1,777 29,871
2006 792 1,142 971 934 1,135 1,133 1,301 31 2,001 29,702
2007 573 1,337 1,053 1,052 1,678 1,178 1,518 18 2,071 31,080
2008 675 1,336 1,091 1,045 1,565 1,250 1,369 18 2,326 31,054
2009 681 1,429 1,282 1,236 1,311 1,246 1,357 30 2,569 43,926
2010 794 1,469 1,359 1,241 1,287 1,466 1,545 60 2,708 34,206
2011 853 1,355 1,357 1,386 1,271 1,480 1,478 45 2,731 33,536
2012 726 1,408 1,333 1,608 1,216 1,663 943 45 2,689 33,924
2013 839 1,361 1,403 1,644 1,105 1,698 1,307 64 3,180 32,454
2014 837 .. 1,352 1,751 1,060 1,669 1,284 63 3,260 33,451
2015 830 .. 1,267 1,791 1,108 1,095 1,308 77 3,438 33,443
2016 888 .. 1,223 1,850 .. 1,437 .. .. .. 35,716
2017 808 .. .. 1,926 .. 1,445 1,189 88 .. 36,304

To give a perspective comparison, according to new data from the Stockholm International Peace Research Institute (SIPRI), the total global military expenditure rose to $1917 billion in 2019[4]. The total for 2019 represents an increase of 3.6 per cent from 2018 and the largest annual growth in spending since 2010. The five largest spenders in 2019 accounted for 62 per cent of expenditure. This is the first time that two Asian states have featured among the top three military spenders. Global military spending in 2019 represented 2.2 per cent of the global gross domestic product (GDP), which equates to approximately $249 per person. 

The average military spending burden was 1.4 per cent of GDP for countries in the Americas, 1.6 per cent for Africa, 1.7 per cent for Asia and Oceania and for Europe and 4.5 per cent for the Middle East (in countries for which data is available).

Now, the above information, two different sets, are there for information only. It appears that over the years, national governments were more prone to have a greater propensity to allocate more resources to various intractable commitments of public resources then to invest in public health research. There are valid and reasonable public sector priorities which underwrite the prioritization of the public sector initiative in various endeavours. But COVID19 has exposed deep vulnerabilities across the globe in matters related to both governance and security. Maintenance of public order and even continuing with the run-of-the-mill business as usual have been insurmountable challenges for even the most advanced administrations and state machineries – calling forth for a new intensity in introspection. To reorient resources into finding solutions which are both robust and resilient and can regenerate under conditions of duress.

But national governments cannot do everything alone. A major segment in this effort must be the NGOs. The NGOs and charitable organizations market expected to reach a value of nearly $385 billion by 2022, significantly growing at a growth rate of around 8% during the forecast period. The growth in the NGOs and charitable organizations market is due to rise in crowd funding[5]. The term “non-governmental organization” was created in Article 71 of the Charter of the United Nations in 1945. An NGO can be any kind of organization provided that it is independent from government influence and is not-for-profit[6]. There are an estimated 10 million non-governmental organizations (NGOs) worldwide[7] – with major players include Wikimedia, BRAC, Acumen Fund, Cure Violence and Medecins Sans Frontiers[8]. If NGOs were a country, they would have the 5th largest economy in the world[9]. Nearly one in three (31.5%) people worldwide donated to charity in 2015 and one in four (24%) volunteered[10]. Probably because of the community participation, Eighty percent of global citizens agree that nongovernmental organizations (NGOs) make it easy to be involved in positive social change[11].

But where do the NGOs fit in in the global scenario for health research and development? What is the priority for the individuals and communities that they serve? These are valid questions and queries that any individual could have, and these are also areas which warrant immediate attention from the NGO sector – as it purportedly serves the communities and champions their causes. Is it possible for the NGOs to commit themselves in creating a robust global R&D structure in medical research? Particularly at a time when massive access to hitherto unimaginable information resources and simulations are accessible on the fingertip? Is it possible to create interconnected networks of laboratories basically surviving on the fringes of the human existence in the fields of knowledge? Are they not valid expectations for the individual too?

What if we can think of creating pools of both researchers and funds for research through the NGO sector and equitize such pools with private individual underwritings at a nominal price and also create a risk buffering mechanism? Can the NGO sector take the lead in creating funding arrangements which would ensure that the private individual can subscribe to valid research initiatives and research data into health research particularly in cases of epidemics or pandemics? Can the NGO sector tend to the safety net needs for highly infectious and deadly diseases? Often it is far easier for the NGOs to reach the remotest of regions before the public sector recourses can be mobilized for action.

What if we devise instruments which the individuals and the communities can subscribe and then those instruments could be underwritten by the public sector bodies responsible? Probably, that would give both the fluidity and the velocity that an augmented recourse to any current or future epidemic or pandemic that any nation or any country would face anywhere in the world.

About the Author: Dr. Syed Muntasir Mamun is with the Said School of Business, Oxford, UK and CHD International Advisory Board Member.

Disclaimer: Views expressed are the authors own. CHD Group takes no liability on behalf or for the contents expressed.



[2] The OECD Structural Analysis (STAN) database defines total expenditure on health as the sum of expenditure on activities that – through application of medical, paramedical and nursing knowledge and technology – has goals of: promoting health and preventing disease, curing illness and reducing premature mortality, caring for persons affected by chronic illness who require nursing care, caring for persons with health-related impairments, disability and handicaps who require nursing care, assisting patients to die with dignity, providing and administering public health, providing and administering health programmes, health insurance and other funding arrangements. 










Leave a Reply

Your email address will not be published. Required fields are marked *

Translate »
Open chat
Hello 👋
Greetings from CHD Group,

How can I help you today?